Introduction {#S1}
============

The female genital tract (FGT) comprises different compartments with unique anatomical and immunological features, which all serve two main tasks: protection against invading pathogens and maintenance of a favorable environment for fertilization.^[@R1]^ The mucosa of the FGT provides an extraordinary barrier composed of an epithelium covered by mucus, and harbors numerous effector cells belonging to the innate and adaptive arms of the immune system.^[@R2]^ The mucosa of the uterus (endometrium) and the canal connecting the uterus and vagina (endocervix) are lined by a monolayer of columnar epithelial cells, and undergo major structural and functional changes during the menstrual cycle.^[@R2]^ The portion of the uterus facing the vaginal lumen (ectocervix) and the vagina display a thick squamous epithelium. Between the endocervix and ectocervix, where the epithelium transforms from single- to multi-layered, lays the transformation zone that is characterized by a remarkable abundance of immune cells compared to the rest of the FGT.^[@R2],[@R3]^

Although the mechanisms regulating immune responses in the FGT are not fully understood, the combined defenses of the genital mucosa effectively shield the host from pathogenic microbes as demonstrated, for instance, by the low efficiency of vaginal HIV-1 transmission.^[@R4]^ To this purpose, immediate immune responses at the site of microbial infection are mediated by cellular and soluble innate factors, which constitute a first line of defense and play a major role in shaping local adaptive immune responses.^[@R1],[@R5],[@R6]^

Mucosal-associated invariant T (MAIT) cells are a recently described innate T cell population, which is abundant in mucosal tissues, blood, and liver.^[@R7]-[@R9]^ MAIT cells express a semi-invariant T cell receptor (TCR), including Vα7.2 coupled with restricted Jα segments (Jα33, Jα12, or Jα20), and limited Vβ repertoires.^[@R10],[@R11]^ Human MAIT cells are defined by the surface expression of their semi-invariant TCR in combination with the high expression of the C- type lectin CD161 and the interleukin (IL)-18 receptor α-subunit (IL-18Rα).^[@R9],[@R12]^ Mature MAIT cells display an effector memory phenotype and exhibit a distinct transcriptional profile, expressing promyelocytic leukemia zinc finger (PLZF) and retinoic acid-related orphan receptor γt (RORγt) transcription factors.^[@R8],[@R9]^ MAIT cells also express classical effector T cell T-box transcription factors T-bet and Eomesodermin (Eomes) as well as Helios, a transcription factor involved in T cell activation and proliferation.^[@R13]-[@R15]^ Decreased expression of these transcription factors in chronic HIV-1 infection is associated with MAIT cell depletion in circulation and functional impairment of MAIT cells following bacterial stimulation.^[@R13]^ MAIT cells recognize microbial vitamin B2 metabolites presented via the evolutionarily conserved major histocompatibility complex (MHC) class I-related (MR) 1 molecule.^[@R7],[@R12],[@R16],[@R17]^ Upon activation, these cells have the capacity to produce cytokines such as interferon (IFN)γ, tumor necrosis factor (TNF), IL-17, and IL-22, suggesting their involvement in both antimicrobial responses and preservation of mucosal barrier integrity.^[@R8],[@R12],[@R18]^ Furthermore, MAIT cells have been shown to be associated with protection against mycobacterial infections in both mice and humans.^[@R12],[@R19],[@R20]^

Despite the growing body of research on MAIT cells in humans, their presence in the FGT has to date not been investigated. In the current study, we characterized the localization and phenotype of MAIT cells in the mucosa from different compartments of the FGT in healthy women and compared them to circulating MAIT cells. Using an *ex vivo* model of bacterial stimulation with *Escherichia coli (E. coli)*, we analyzed the functionality of MAIT cells by measuring the production of selected cytokines and effector proteins relevant to antimicrobial responses and mucosal homeostasis. We found that MAIT cells reside in the mucosa throughout the FGT, are biased towards IL-17 and IL-22 expression, and may thus contribute to anti-microbial immune defenses at this site. Our data point to MAIT cells as an active component of the early immune defenses of the FGT and serve as the basis for further investigation of their role in women\'s health and disease.

Results {#S2}
=======

Clinical data and CD4^+^ and CD8^+^ T cell counts in the study populations {#S3}
--------------------------------------------------------------------------

Study participants (n=38, median age 49 years, range 35-62 years) were recruited at the St. Göran Hospital gynecological clinic where they were admitted to undergo hysterectomy due to benign conditions. Before surgery, a physician interviewed all patients and they were all found to have good general health. Individuals who were seropositive for Human papilloma virus (HPV), reported symptoms or clinical signs of sexually transmitted infections at the time of surgery or during three months prior to surgery, or were treated with corticosteroids or other systemic immunosuppressive therapy were excluded from the study.

Thirty-five women were premenopausal and three were postmenopausal. Neither age nor menstrual status affected the down-stream immunological comparisons performed between study participants (data not shown). Detailed characteristics of the women donating genital tissue are included in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}. Peripheral blood samples were collected from healthy women (n=16) who were in the same age range as the women who underwent hysterectomy (median age 46 years, range 30-60 years). Individuals using immunosuppressive drugs were not eligible as blood donors. Frequencies of CD4^+^ and CD8^+^ T cells in the endometrium, cervix, and blood were determined by flow cytometry, and CD4^+^ and CD8^+^ T cells were defined as CD45^+^CD3^+^CD4^+^ cells and CD45^+^CD3^+^CD8^+^ cells, respectively. The CD4/CD8 ratio in the endometrium and cervix was 0.96 and 1.07, respectively, whereas it was 2.15 in blood. These results are in agreement with previous reports on distribution of CD4^+^ and CD8^+^ T cells in cervicovaginal mucosal tissue.^[@R21]^

MAIT cells and MR1^+^ antigen-presenting cells reside in the upper and lower FGT {#S4}
--------------------------------------------------------------------------------

*In situ* staining was used to determine the localization and distribution of MAIT cells in mucosal specimens from different portions of the FGT, including the endometrium, endocervix, transformation zone, and ectocervix. MAIT cells were defined by immunofluorescent double-staining for Vα7.2 in combination with IL-18Rα, which were co-expressed on all CD161^high^Vα7.2^+^ T cells, a phenotype identifying MAIT cells, isolated from the cervix and endometrium as evaluated by flow cytometry ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). MAIT cells were present throughout the FGT; however they displayed a diverse distribution within the analyzed compartments. Scattered MAIT cells were located in close proximity to and within the glandular epithelium in the lamina propria of the endometrium ([Figure 1a](#F1){ref-type="fig"}). Endocervical MAIT cells were primarily localized adjacent to the simple columnar epithelium ([Figure 1b](#F1){ref-type="fig"}), while in the transformation zone, MAIT cells were primarily found in the lamina propria ([Figure 1c](#F1){ref-type="fig"}). Furthermore, ectocervical MAIT cells were located on both sides of the basal membrane, with the majority residing within clusters of IL-18Rα^+^ cells in the epithelium ([Figure 1d](#F1){ref-type="fig"}). Moreover, *in situ* double staining of Vα7.2 and CD3, as well as of CD3 and CD8, in consecutive tissue sections confirmed that the Vα7.2^+^ cells within the FGT were T cells and localized in proximity to other T cells ([Supplementary Figure 2](#SD1){ref-type="supplementary-material"}). Additional double staining of Vα7.2 and CD8 showed that Vα7.2^+^ cells were also CD8^+^ (data not shown).

We next investigated if MR1^+^ antigen-presenting cells (APCs) were present within the same sites as MAIT cells. Thus, consecutive tissue sections of the endometrium and ectocervix were stained for MAIT cells and MR1^+^ APCs, which were defined by co-expression of MR1 and the APC marker HLA-DR. Similar to MAIT cells, MR1^+^HLA-DR^+^ cells were located within or in close proximity to the glandular epithelium of the endometrium and on both sides of the basal membrane in the ectocervix ([Figure 2a](#F2){ref-type="fig"}). We also characterized the distribution of different APC subsets as well as their expression of MR1 in endometrial and ectocervical tissue samples. In line with previous observations,^[@R22],[@R23]^ we found that Langerin^+^ cells were a minor population in endometrium, while they were more common in the ectocervix. CD11c^+^ dendritic cells were abundant in both compartments (data not shown). Furthermore, MR1 was expressed on CD11c^+^ cells in both the endometrium and ectocervix as well as on a few Langerin^+^ cells in the epithelial compartment of the ectocervix ([Figure 2b](#F2){ref-type="fig"}).

Comparable numbers and CD8/CD4 distribution of MAIT cells in FGT and blood {#S5}
--------------------------------------------------------------------------

Next, flow cytometry was used to enumerate MAIT cells and assess their phenotype in endometrium, cervix, and blood samples. Due to the limited endocervix samples available, the endocervix and ectocervix were combined for this analysis and referred to as cervix. MAIT cells were identified as CD45^+^CD3^+^CD161^hi^ Vα7.2^+^ cells ([Figure 3a](#F3){ref-type="fig"}). MAIT cells isolated from the endometrium and cervix were quantified in comparable amounts ([Figure 3b](#F3){ref-type="fig"}), and accounted for 1% and 1.8%, respectively, of the T cell population, defined as CD45^+^CD3^+^ cells. In blood, MAIT cells represented about 2.1% of T cells, thus accounting for a significantly higher proportion of cells compared to the endometrium (p=0.01), but not the cervix ([Figure 3b](#F3){ref-type="fig"}). MAIT cells preferentially express CD8 with minor populations being CD4^+^ or double negative (CD4^-^CD8^-^). There were significant differences between these three sub-populations in the endometrium (p\<0.0001), cervix (p=0.006) and blood (p\<0.0001). Specifically, the percentage of CD8^+^ MAIT cells among T cells was significantly higher compared to both CD4^+^ MAIT cells and CD4^-^CD8^-^ MAIT cells in all three compartments analyzed: in the endometrium, CD8^+^CD4^-^, CD8^-^CD4^+^, and CD8^-^CD4^-^ MAIT cells were 69%, 12%, and 11% (p\<0.0001); in the cervix 75%, 13%, and 12% (p=0.008); and in blood 84%, 2%, and 8% (p\<0.0001), respectively. Furthermore, in blood, CD4^+^ MAIT cells were significantly lower compared to CD8^-^CD4^-^ MAIT cells (2% vs. 8%, p=0.02) ([Figure 3b](#F3){ref-type="fig"}). Additionally, similar frequencies of these three sub-populations of MAIT cells were observed between the different compartments, except for blood CD4^+^ MAIT cells, which were significantly lower compared to endometrial CD4^+^ MAIT cells (2% vs. 12%, p=0.01) ([Figure 3b](#F3){ref-type="fig"}).

Distinct transcription factor profiles of MAIT cells in the FGT and blood {#S6}
-------------------------------------------------------------------------

We next characterized the expression of IL-18Rα, IL-7 receptor-α chain (CD127), the mucosal homing integrin α4β7, and PD-1, which are expressed on MAIT cells from blood, liver, and other mucosal tissues.^[@R8],[@R18],[@R24]-[@R26]^ MAIT cells from the endometrium, cervix, and blood displayed a universal expression of these markers, which was distinct from conventional CD8^+^ and CD4^+^ T cells ([Supplementary Figure 1b](#SD1){ref-type="supplementary-material"}).

We further characterized the transcription factor expression profile of endometrial, cervical, and blood MAIT cells. Similar expression levels of PLZF, RORγt, Helios, Eomes, and T-bet were observed between MAIT cells from the endometrium and cervix. However, endometrial MAIT cells and cervical MAIT cells, in comparison to those in blood, showed significantly lower expression levels of PZLF (median GMFI: 121 vs. 156; p=0.01) and Eomes (median GMFI: 776 vs. 1689; p=0.01), respectively ([Figure 4a](#F4){ref-type="fig"}). Despite these differences, the overall expression pattern of the transcription factors in MAIT cells was similar between the three compartments and distinct from conventional T cells ([Figure 4b](#F4){ref-type="fig"}) ([Supplementary Figure 3](#SD1){ref-type="supplementary-material"}).

MAIT cells in the FGT are biased towards IL-17 and IL-22 production upon *E. coli* stimulation {#S7}
----------------------------------------------------------------------------------------------

We next investigated the activation and cytokine production of MAIT cell from the FGT and blood in responses to bacteria encoding the riboflavin biosynthesis pathway. Endometrial and cervical samples were pooled in order to achieve a sufficient yield of cells needed for stimulation experiments, and these cells were referred to as FGT cells. Stimulation of cells from the FGT and blood with *E. coli*, or with phorbol 12-myristate 13-acetate (PMA), triggered production of IFN-γ, TNF, IL-17A (further referred to IL-17), IL-22, and GrzB in MAIT cells ([Figure 5a](#F5){ref-type="fig"}). To increase the sensitivity of our bacterial stimulation assay, CD28 co-stimulation was included; however this did not alter the response profiles of MAIT cells ([Supplementary Figure 4a](#SD1){ref-type="supplementary-material"}). Additionally, stimulation with *E. coli* in the presence of MR1-blocking antibody resulted in a reduction of MAIT cell production of IFN-γ, TNF, and IL-17, indicating that the *in vitro* stimulation of MAIT cells occurred through bacterial antigen presentation on MR1 molecules. Notably, production of IL-22 and GrzB by MAIT cells was not altered by the MR1-blocking antibody ([Supplementary Figure 4b](#SD1){ref-type="supplementary-material"}).

On average, *E. coli* stimulation induced IL-17 and IL-22 in a significantly higher fraction of MAIT cells from the FGT than in blood (9% vs. 1%; p=0.0005 and 2% vs. 0.2%; p=0.04, respectively). In contrast, the production of IFN-γ, TNF, and GrzB in response to *E. coli* was lower in FGT-derived MAIT cells compared to blood (IFN-γ 10% vs. 65%; p=0.004, TNF 11% vs. 38%; p=0.008, and GrzB 41% vs. 87%; p=0.003) ([Figure 5b](#F5){ref-type="fig"}).

We next investigated if the preferential IL-17 and IL-22 production upon *E. coli* stimulation in the FGT was restricted to MAIT cells. We found that the total IL-17 and IL-22 production by CD45^+^ lymphocytes was two-fold and 20-fold higher in the FGT compared to blood while in contrast, CD45^+^ lymphocytes in the FGT produced lower levels of IFN-γ and TNF compared to blood ([Supplementary figure 5a](#SD1){ref-type="supplementary-material"}). We further assessed the production of these cytokines by CD3^-^CD45^+^ (non-T cells) and CD3^+^CD45^+^ (T cells) cells in the FGT and blood and, as expected, these cells had a different cytokine expression profile, depending on their anatomical origin ([Supplementary Figure 5b](#SD1){ref-type="supplementary-material"}). Furthermore, in line with previous findings showing that Th17 cells are a major subset in the FGT,^[@R27]^ we found that the frequencies of both IL-17 and IL-22 producing CD4^+^ T cells were significantly elevated in the FGT compared to blood ([Supplementary Figure 5c](#SD1){ref-type="supplementary-material"}). Collectively these data indicate that MAIT cells as well as other immune cells within the FGT are more prone to produce IL-17 and IL-22 after *E. coli* stimulation.

MAIT cells in the FGT have a distinct polyfunctional profile upon *E. coli* stimulation {#S8}
---------------------------------------------------------------------------------------

We further assessed the, *E. coli* induced, polyfunctional profile of MAIT cells from the FGT and blood, using the SPICE software. The majority of MAIT cells in the FGT were monofunctional cells (68.6%), with lower frequencies of bi- and trifunctional cells (17.5% and 13.3%, respectively). In contrast, circulating MAIT cells had similar proportions of mono- and bifunctional cells (43.5% and 38.9%, respectively), and a lower frequency of trifunctional cells (17.1%). For both sites, the frequency of tetra- and penta- functional MAIT cells were low, although the FGT appeared to have slightly higher proportions of these highly polyfunctional cells (2.4% vs. 0.5%, respectively) ([Figure 6a](#F6){ref-type="fig"}). The polyfunctional profile of MAIT cells (i.e. cells exhibiting \>1 function) from the FGT was different from that observed in blood. Specifically, the frequencies of GrzB^+^IL-17^+^MAIT cells were significantly elevated in the FGT compared to blood (p=0.01), while significantly lower frequencies of MAIT cells in the FGT comprised of bifunctional GrzB^+^IFNγ^+^ (p\<0.0001) and GrzB^+^TNF^+^ (p=0.02) cells. Likewise, similar observations were noted for the trifunctional MAIT cells, with significantly higher proportion of GrzB^+^IFN-γ^+^IL-17^+^ and GrzB^+^IL-17^+^TNF^+^ cells in the FGT vs. blood (p= 0.05 and p=0.05 respectively), and significantly lower proportion of GrzB^+^IFNγ^+^TNF^+^ as well as GrzB^+^IL-22^+^TNF^+^ cells in the FGT vs. blood (p= 0.005 and p=0.004 respectively) ([Figure 6b](#F6){ref-type="fig"}). Noteworthy, while monofunctional GrzB^+^ MAIT cells were present in both compartments, single-producing IL-17^+^ MAIT cells (p=0.0009) and co-producing IL-17^+^IL-22^+^ MAIT cells were more common in the FGT ([Figure 6b](#F6){ref-type="fig"}).

Discussion {#S9}
==========

This is the first study to show that MAIT cells, as well as MR1^+^ APCs, are present in the upper and lower FGT of healthy women. MAIT cells displayed a scattered distribution throughout the FGT, except for the ectocervix where the majority localized within clusters of IL-18Rα^+^ cells in the epithelium. As the upper FGT is considered to be a relatively "sterile" milieu compared to the lower FGT,^[@R1],[@R2]^ the preferential localization of MAIT cells in the ectocervical epithelium may serve a functional purpose by sensing potential pathogenic microbes and the commensal microbiota populating the cervicovaginal environment. For instance, the *Lactobacillus* species, which belong to the commensal flora of the FGT, have stimulatory effects on murine MAIT cells.^[@R12],[@R28],[@R29]^ Since activation of MAIT cells is primarily MR1-dependent,^[@R7],[@R12],[@R16]^ we also investigated the presence of MR1^+^ APCs in the FGT. MR1 was expressed on dendritic cells that were localized at the same anatomical sites as MAIT cells within the FGT, thus indicating that MAIT cells and MR1^+^ APC have the potential to interact.

MAIT cells in the FGT and in blood displayed similar frequency and a shared phenotype with expression of IL-18Rα, CD127, PD-1, and α4β7, and comparable CD4/CD8 distribution. Furthermore, in both anatomical sites MAIT cells displayed a transcription factor profile with expression of PLZF, RORγt, Helios, Eomes, and T-bet, distinct from conventional CD4^+^ and CD8^+^ T cells. These observations indicate that MAIT cells residing in the genital mucosa display an effector memory-like phenotype and thus have the capacity to act as a first line of defense against invading microbial pathogens. Interestingly, PLZF and Eomes expression was lower in MAIT cells from the FGT as compared to blood, indicating that the transcriptional profile may differ to some extent between circulating and mucosal MAIT cells.

In order to investigate the potential role of MAIT cells in the mucosal defense against microbes, we characterized the cytokine profile of FGT- and blood-derived MAIT cells in response to *E. coli* stimulation. Mildly-fixed *E. coli* was used as an *ex vivo* model of bacterial stimulation. *E. coli* is not part of the normal commensal genital microflora in healthy women and is the most common gram-negative pathogen causing anaerobic vaginitis. The prevalence of diagnosed symptomatic anaerobic vaginitis varies from 5-10% in non-pregnant women.^[@R30]^ Here we showed that although *E. coli*-stimulated MAIT cells from both compartments were capable of producing GrzB, IFN-γ, TNF, IL-17, and IL-22, the FGT-derived MAIT cells were more prone to produce IL-17 and IL-22, whereas blood MAIT cells preferentially produced IFN-γ, TNF, and GrzB. The preferential IL-17 and IL-22 production in genital mucosa was not limited to MAIT cells since also other immune cells within the FGT produced these cytokines, highlighting that the FGT environment is more predisposed for production of these cytokines.

Our stimulation data was additionally validated by assessing *E. coli*-induced activation of MAIT cells in the presence of an MR1-blocking antibody, which significantly reduced the production of IFN-γ, TNF, and IL-17. Notably, we observed that expression levels of GrzB and IL-22 were not sensitive to MR1 blocking. This is in agreement with previous studies showing that GrzB production by MAIT cells is highly sensitive to the influence of a range of innate, inflammatory, and homeostatic cytokines, including IL-7, IL-12, IL-15 and IL-18 in an antigen-independent and MR1-independent manner.^[@R13],[@R31]-[@R33]^ This may possibly also be applicable to MAIT cell IL-22 production, but it requires further investigation.

Deeper analyses of the *E. coli* induced cytokine profile of MAIT cells revealed that they displayed distinct polyfunctional profiles depending on their anatomical origin. FGT-derived MAIT cells displayed a mixed Th1/Th17 phenotype, with co-expression of Th1 effector molecules and IL-17, and to a lesser extent IL-22. In contrast, circulating MAIT cells predominantly co-expressed GrzB, IFNγ, and TNF. We also observed a relatively large GrzB single-producing MAIT cell population, which may possibly represent a subset of MAIT cells that produce cytokines other than those examined in this study. Our data thus reveal that FGT-derived MAIT cells respond to bacterial stimuli in a fashion that is unique to the FGT, supporting their importance as early immune mediators of immune responses upon infection of the FGT.

This difference in cytokine production and polyfunctionality is intriguing, considering that IL-17 and IL-22 play a pivotal role in mucosal immune responses.^[@R34],[@R35]^ IL-17 is crucial for expression of antimicrobial peptides and antifungal defenses in skin and mucosal tissues, and IL-22 is also involved in regulation of the mucosal barrier integrity by promoting epithelial cell proliferation and epithelial tight junction protein expression in mucosal tissues.^[@R34]-[@R37]^ Additionally, IL-17 and IL-22 levels are increased in genital secretions of women with various genital infections, including trichomonas, chlamydia, and gonorrhea; however the source of these cytokines in the FGT remains unclear.^[@R38]-[@R40]^ MAIT cells are located close to the lumen of the FGT and can thus possibly serve as sentinels for incoming pathogens. It would hence be interesting to further investigate if *Chlamydia* and *Neisseria gonorrhoeae* could stimulate cytokine production by MAIT cells, in a similar manner as shown here for *E. coli*. Furthermore, IL-1β and IL-6 that are known to be important for IL-17 and IL-22 responses, are present in secretions from the upper and lower FGT and are significantly upregulated during genital infections locally, but not systemically.^[@R40]-[@R42]^ Due to limitations in sample availability, these cytokines were not measured here. However, IL-1β and IL-6 have been shown to be higher in genital secretions compared to blood in healthy premenopausal women.^[@R43]^ Thus, one may speculate that the preferential IL-17 and IL-22 production by MAIT cells in the FGT may be modulated by the local microflora and cytokine environment.

The difference in functional profile between MAIT cells in the FGT and blood may also be influenced by differences in the transcriptional profile of these cells. A recent study by Rahimpour *et al*. showed that murine MAIT cells displayed functional plasticity associated with RORγt and T-bet expression levels resulting in either preferential IL-17 or IFN-γ production.^[@R44]^ Our data showed that FGT-derived MAIT cells displayed lower Eomes and PLZF expression than MAIT cells from blood. However, since the transcription factor profile of MAIT cells was assessed in unstimulated samples, due to limited sample availability, it is difficult to ascertain the role in driving the preferential functional phenotypes of MAIT cells in the FGT.

A potential caveat in this study is that FGT and blood samples were not derived from the same donors. However, all study subjects were healthy women within the same age range and none used immunosuppressive drugs. Another limitation of working with tissue biopsies obtained from the human FGT is the limited sample availability. Additionally, while it would have been preferable to distinguish the response to *E. coli* between the upper and lower FGT, this was not feasible due to the relatively low numbers of MAIT cells retrieved. Furthermore, sex hormones affect the FGT and the immune cell distribution within the mucosa.^[@R2]^ Novak *et al*. reported higher numbers of MAIT cells in blood from women who were of reproductive age (15-50 years of age) compared to age-matched men, suggesting that sex hormones may influence the number of MAIT cells in blood.^[@R45]^ Although we did not observe any differences in the frequency of MAIT cells between pre- and postmenopausal women, the impact of sex hormones on MAIT cells should be further investigated.

In summary, this is the first study to show that MAIT cells, as well as MR1^+^ APCs, are localized near the luminal surface of the genital mucosa of healthy women. The combination of MAIT cell localization in the mucosa and their capacity to rapidly produce cytokines suggests that they may be an important component of the first line of defense against invading pathogens. In virtue of their polyfunctionality as well as preferential IL-17 and IL-22 production compared to their circulating counterparts, mucosal MAIT cells together with other innate immunity components and the local microflora, may also act as keepers of mucosal homeostasis and barrier integrity. The present study provides a foundation for future studies of mucosal MAIT cells in acute and chronic genital infections, which will ultimately lead to a better understanding of the mechanisms regulating immunity in the FGT.

Methods {#S10}
=======

Study population and sample collection {#S11}
--------------------------------------

Uterine tissue samples were obtained from 38 Swedish women who underwent hysterectomy for nonmalignant and noninflammatory conditions such as heavy menstrual bleeding or benign myoma at the St. Göran Hospital in Stockholm, Sweden. HPV- infection was diagnosed with the PapilloCheck HPV genotyping test (Greiner Bio-One GmbH, Kremsmünster, Austria) by the accredited microbiological laboratory service at the Karolinska University Hospital in Stockholm, Sweden. Peripheral blood samples were collected from healthy Swedish women in the same age range as women who underwent a hysterectomy, and were recruited at the Blood Transfusion Clinic at the Karolinska University Hospital in Stockholm, Sweden. Written informed consent was obtained from all donors and ethical approval was obtained from the Regional Ethical Review Board of Stockholm.

Processing of uterus specimens and peripheral blood mononuclear cells {#S12}
---------------------------------------------------------------------

Samples of endometrium and cervical mucosa were collected by a pathologist immediately after the hysterectomy. The amount of tissue obtained varied depending on the overall dimension of the surgical specimens. At least 1 cm^2^ of mucosa (approximately 500 mg wet weight) was required for downstream applications. Samples were maintained in ice-cold RPMI 1640 supplemented with 50 μg/ml of gentamicin and 2.5 μg/ml of Fungizone (Gibco, Life Technologies Europe BV, Stockholm, Sweden), and processed within 24 hours of surgery. For each specimen, the mucosa was separated from any residual underlying stromal or muscular tissue and dissected into approximately 8 mm^3^ blocks using a scalpel and tweezers, as previously described.^[@R46]^ One or two tissue blocks were snap-frozen immediately after dissection and cryopreserved at -80°C for *in situ* staining. The remaining tissue blocks were digested with 0.1 mg/ml of DNase I (Roche, Basel, Switzerland) and 0.5 mg/ml of Collagenase II (Sigma-Aldrich, St. Louis, MO, USA) in a thermoshaker (Labnet International, Edison, NJ, USA) rocking at 1400 rpm for 30 min at 37°C. Digested tissue blocks were mechanically disrupted with a pestle. The obtained cell suspension was filtered through a 70-μm cell strainer (BD Biosciences, San Jose, CA, USA) and washed in phosphate-buffered saline (PBS) by centrifugation at 400×*g* for 5 min. For flow cytometry, mononuclear cells (MNCs) were isolated by density gradient centrifugation at 900× *g* for 20 min using Ficoll-Hypaque (Axis-Shield, Dundee, Scotland). Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll-Hypaque density gradient centrifugation and either allowed to rest overnight in complete medium before use in the functional assay (see below) or cryopreserved in liquid nitrogen until required for the phenotypic analysis (see below).

*In situ* fluorescence staining {#S13}
-------------------------------

*In situ* staining was performed on 8-μm thick sections of the cryopreserved tissue samples. The tissue sections were fixed in 2% formaldehyde for 10 min and then washed with PBS. Immunofluorescent double-staining of Vα7.2 and IL-18Rα; Vα7.2 and CD3; Vα7.2 and CD8; CD3 and CD8 as well as of MR1 and HLA-DR, MR1 and CD1 1c; MR1 and Langerin were done sequentially. The following monoclonal primary antibodies were used: mouse anti-human Vα7.2 antibody (clone 3C10, BioLegend, San Diego, CA, USA); goat anti-human IL-18Ra antibody (AF840, R&D Systems, Minneapolis, MN, USA); rabbit anti-human CD3 antibody (clone SP7, Abcam, Cambridge, UK); Alexa 488 conjugated mouse anti-human CD8 antibody (clone RPA-T8, BD Biosciences); mouse anti-human MR1 antibody (clone 8F2.F9,^[@R47]^ a kind gift from Dr. Ted Hansen); biotinylated mouse anti-human HLA-DR antibody (clone L243, BD Biosciences) that was used in combination with streptavidin-conjugated Alexa Fluor 488 (Molecular Probes, Life Technologies); FITC conjugated mouse anti-human CD11c (clone B-ly6, BD Biosciences); and rat anti-human Langerin (clone 929F3.01, Dendritics, Lyon, France). The following secondary antibodies were used: Alexa Fluor 594 or 488-conjugated donkey anti-mouse IgG antibody; Alexa Fluor 488-conjugated donkey anti-goat IgG antibody; Alexa Fluor 488-conjugated donkey anti-rat IgG antibody; Alexa Fluor 594-conjugated donkey anti-rabbit IgG antibody (Molecular Probes, Life Technologies Europe BV, Stockholm, Sweden). The tissue sections were mounted with Vectashield containing DAPI (Vector Laboratories, Burlingame, CA, USA). Negative controls were included and consisted of incubations in the presence of secondary antibody alone. Images were acquired on a DMR-X microscope (Leica, Wetzlar, Germany) with a Retiga 2000R camera (QImaging, Surrey, Canada). Acquired images were processed using Image-Pro Premier 9.1 software (Media Cybernetics, Rockville, MD, USA).

Flow cytometry {#S14}
--------------

Cell-surface staining was performed using directly-conjugated antibodies and cells were fixed in Cytofix/Cytoperm or in Transcription Factor Fixation/Permeabilization buffer (both from BD Biosciences) as appropriate. Intracellular staining was performed in Perm/Wash or Transcription Factor Perm/Wash buffer as appropriate (both from BD Biosciences). Samples were acquired on an LSRFortessa flow cytometer (BD Biosciences) equipped with 405, 488, 561, and 639 nm lasers. Single-stained polystyrene beads (BD Biosciences) were used for compensation purposes. Software-based compensation was performed using the compensation platform in FlowJo software version 9.6 (Tree Star, Ashland, OR, USA). Distribution of effector molecules expressed by MAIT cells was compared using SPICE software version 5.35.^[@R48]^ Antibodies used in the experiments are listed in [Supplementary Table 2](#SD1){ref-type="supplementary-material"}.

Functional assay {#S15}
----------------

MAIT cell functions were determined *in vitro* using a formaldehyde-fixed *E. coli* stimulation (D21 strain, fixed in 1% formaldehyde for 5 min multiplicity of infection=5) in the presence of 1.25 μg/ml anti-CD28 mAb (clone L293, BD Biosciences) and, in selected experiments, 20 μg/ml anti-MR1 mAb (clone 26.5; Biolegend) or IgG2 isotype control (clone MOPC-173, BioLegend). PBMCs or FGT-derived MNCs were further cultured for 24 hours at 37°C and 5% CO~2~ in RPMI medium supplemented with 10% fetal calf serum and 50 μg/ml gentamicin (Gibco). Monensin (Golgi Stop, BD Biosciences) was added during the last 6 hours of the stimulation. Cells stimulated for 6 h with PMA/ionomycin (Leukocyte Activation Cocktail, BD Biosciences) and in the presence of monensin were included in parallel as positive controls.

Statistical analyses {#S16}
--------------------

Statistical significance between continuous variables was assessed using the Mann-Whitney *U* test for comparisons of independent samples and the Wilcoxon signed rank test for paired samples. Furthermore, multiple comparison analysis were performed with the use of the Kruskal-Wallis test followed by Dunn\'s post-hoc test for independent samples and the Friedman test followed by Dunn\'s post-hoc test for paired samples. Prism 5.00 for Windows (GraphPad Software, CA, USA) was used for statistical analysis and a p-value \<0.05 was considered significant. Permutation tests were analyzed using the data analysis program SPICE version 5.35.^[@R48]^

Supplementary Material {#S17}
======================

###### 

**Supplementary Figure 1**. (**a**) Representative plot showing the co-expression of CD161 on CD45^+^IL-18Rα^+^Vα7.2^+^ and co-expression of IL-18Rα on CD45^+^CD3^+^CD161^high^Vα7.2^+^ (MAIT) cells obtained from cervix. (**b**) Representative histograms of one of three replicate experiments showing the expression levels (GMFI, geometric mean intensity fluorescence) of IL-18Rα, CD127, α4β7, and PD-1 in MAIT cells (red), CD4^+^ T cells (blue), and CD8^+^ T cells (green) from the endometrium, cervix and blood.

**Supplementary Figure 2**. Localization and spatial distribution of Vα7.2^+^T cells and CD8^+^T cells in the FGT. Representative immunofluorescence images of (**a**) endometrial, (**b**) endocervical, (**c**) transformation zone, and (**d**) ectocervical tissue sections stained for CD3^+^ (red) and Vα7.2^+^ (green) cells in the first three columns and for CD3^+^ (red) and CD8^+^ (green) in the last column. Double-positive cells are shown in yellow, Va7.2^+^T cells are indicated by the white arrows. DAPI (blue) was used as a counterstain for visualization of cell nuclei. The images were collected with 40× and 20× objectives. The scale bars are 60 μm in the images in the first three columns and 200 μm in the images in the last column.

**Supplementary Figure 3**. Scatter plots represent the expression levels of PLZF, RORγt, Helios, Eomes, and T-bet transcription factors in MAIT cells (red), CD4^+^ T cells (blue), and CD8^+^ T cells (green) from the endometrium (n=7), cervix (n=4), and blood (n=6). Each symbol represents a different patient; endometrium (circle), cervix (triangle), and blood (square). Horizontal lines represent the median ± interquartile range. \*p\<0.05.

**Supplementary Figure 4**. Representative histogram and dot plots showing IFN-γ, TNF, IL-17, IL-22 and GrzB production by MAIT cells (**a**) from three donors, in unstimulated controls (black line) and upon stimulation with *E.coli* alone (blue line) and in the presence of α-CD28 (red line); (**b**) from FGT-derived cells of three donors, in unstimulated controls (upper panel) and upon stimulation with *E. coli* in the presence of the IgG2a isotype control (middle panel) or the MR1- blocking antibody (lower panel).

**Supplementary Figure 5**. Cytokine production by immune cells in the FGT (n=10) vs. blood (n=6). (**a**) Bar chart represents fold change in IL-17, IL-22, IFN-γ, and TNF production by CD45+ lymphocytes from FGT vs. blood. (**b**) Pie charts of compiled data showing percentage of median values of IL-17, IL-22, IFN-γ, and TNF production in the FGT and blood by CD3^-^CD45^+^ (red) and CD3^+^CD45^+^ (blue) cells as well as by MAIT, CD4^+^, CD8^+^, CD4^-^CD8^-^ and other cells; the different shades of blue represent different T cell subsets. (**c**) Scatter plot represents IL-17 and IL-22 production by CD4^+^ T cells from the FGT and blood. Each symbol represents a different patient; FGT (circle) and blood (square). Horizontal lines represent median ± interquartile range. \*\*\**P*\<0.001.

Supplementary Table 1. Characteristics of the patients undergoing hysterectomy

Supplementary Table 2. Antibodies used in flow cytometry
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![Localization and spatial distribution of MAIT cells in the FGT. Representative immunofluorescence images of (**a**) endometrial (n=6), (**b**) endocervical (n=2), (**c**) transformation zone (n=2), and (**d**) ectocervical (n=6) tissue sections stained for Vα7.2^+^ (red) and IL-18Rα^+^ (green) cells. To be noted, the 40× pictures of the ectocervix were rotated 90° right from the 10× overview picture. DAPI (blue) was used as a counterstain for visualization of cell nuclei. Double-positive (MAIT) cells are shown in yellow and are indicated by the white arrows. The images were collected with 10× and 40× objectives. The scale bars are 250 μm in the images in the first column and 60 μm in the images in the other three columns.](nihms765873f1){#F1}

![Localization and spatial distribution of MR1^+^ APCs in the endometrium and ectocervix. Representative immunofluorescence images of endometrial (n=2) and ectocervical (n=2) tissue sections stained for (**a**) MR1 (red) and HLA-DR (green); the scale bars are 250 μm in the images in the first column and 60 μm in the images in the other three columns. (**b**) Representative immunofluorescence images of endometrial and ectocervical tissue sections stained for MR1 (red) with CD11c (green) and MR1 (red) with Langerin (green); the scale bars are 60 μm. Double-positive cells are shown in yellow and are indicated by the white arrows. DAPI (blue) was used as a counterstain for visualization of cell nuclei. The images were collected with 10× and 40× objectives.](nihms765873f2){#F2}

![Enumeration of the frequency of MAIT cells in the FGT and blood. (**a**) MAIT cell (CD161^high^Vα7.2^+^) gating strategy and representative scatter plots. (**b**) Frequencies of MAIT cells out of T cells (CD45^+^CD3^+^) from the endometrium (n=19), cervix (n=14), and blood (n=16). (**c**) Frequencies of CD8 (CD4^-^CD8^+^), CD4 (CD4^+^CD8^-^), and DN (CD4^-^CD8^-^) MAIT cells out of total MAIT cells from the endometrium (n=10), cervix (n=5), and blood (n=10). The cervix samples consisted of pooled endocervical and ectocervical cells. Each dot represents a different patient; endometrium (circle), cervix (triangle), and blood (square). Horizontal lines represent median ± interquartile range. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001.](nihms765873f3){#F3}

![Expression of transcription factors in MAIT cells in the FGT and blood. Expression levels of PLZF, RORγt, Helios, Eomes, and T-bet transcription factors in MAIT cells (GMFI, geometric mean intensity fluorescence). (**a**) Scatter plots represent the expression levels of transcription factors in MAIT cells from the endometrium (n=7), cervix (n=4), and blood (n=6). Each symbol represents a different patient; endometrium (circle), cervix (triangle), and blood (square). Horizontal lines represent the median ± interquartile range, \**P*\<0.05. (**b**) Representative histograms showing the expression levels of transcription factors in MAIT cells (red), CD4^+^ T cells (blue), and CD8^+^ T cells (green) from the endometrium (n=7), cervix (n=4), and blood (n=6).](nihms765873f4){#F4}

![Cytokine and GrzB production profile by MAIT cells in the FGT and blood upon *E. coli* stimulation. (**a**) Representitive dot plot showing IFN-γ, TNF, IL-17, IL-22 and GrzB production by MAIT cells from FGT and blood samples that were either unstimulated (upper panel; n=8), stimulated with *E.coli* (middle panel; FGT n=10, blood n=6), or stimulated with PMA (lower panel; n=4). (**b**) Frequencies of cytokines and GrzB production by MAIT cells from the FGT (n=10) and blood (n=6). Each symbol represents a different patient; FGT (circle) and blood (square). Horizontal lines represent median ± interquartile range. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001.](nihms765873f5){#F5}

![Polyfunctional characterization of MAIT cells from the FGT (n=10) and blood (n=6), using SPICE software. (**a**) Left and right pie charts representing the number of functions expressed by MAIT cells from the FGT and blood respectively (**b**) Bar and pie charts showing the distribution of GrzB, IFN-γ, IL-17, IL-22 and TNF combinations expressed by MAIT cells from the FGT (blue) and blood (red). Permutation test was performed between the bar charts. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001.](nihms765873f6){#F6}
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